Overall, these results confirm that in addition to BMPR2 silencing, HPAECs treated with VEGF, another known PAH-inducing cellular mechanism, leads to endothelial dysfunction and hyper-migration mediated by the nmMLCK pathway. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.